Search results
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Investor's Business Daily· 3 days agoBut Abbott stock slipped a fraction at the close. The Food and Drug Administration signed off on...
Scotiabank cuts Biomea Fusion shares target, notes FDA clinical hold concerns By Investing.com
Investing.com· 6 days ago(NASDAQ: BMEA) shares, reducing it to $21.00 from the previous $41.00. The adjustment follows the...
Why This Biotech Stock Crashed 67% To A Two-Year Low
Investor's Business Daily· 6 days agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA noted there were possible
Compounded Semaglutide vs. Ozempic: Effectiveness and Safety Review
Healthline· 7 days agoCompounded semaglutide and Ozempic are different products. While both may be used to help manage...
I lost 45 pounds in 3 months — thanks to a ‘game changer’ new technique
NY Post via Yahoo News· 4 days ago"I've been able to do fantastic improvements in my quality of life, and so I'm very, very happy and...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
LA Times via Yahoo News· 1 day agoResearchers at McAfee have found a near tripling in the number of phishing attempts and malicious...
U.S. FDA places hold on Biomea's diabetes trials
Reuters· 7 days agoBiomea Fusion said on Thursday the U.S. Food and Drug Administration had placed a clinical hold on its ongoing mid ...
Syntis Bio launches oral therapies for metabolic diseases
Pharmaceutical Technology via Yahoo Finance· 1 day agoSyntis CEO Rahul Dhanda stated: “We are excited by the...pioneering more effective treatments across...
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time...
Motley Fool via Yahoo Finance· 2 days agoRybelsus is an oral version of semaglutide that Novo Nordisk launched in 2019 for the treatment of ...
Biomea Fusion Down 61% on Clinical Hold for Diabetes Drug
Morningstar· 7 days agoBiomea Fusion shares fell 61% to $4.40 after hours as the company said the Food and Drug Administration placed a full ...